GE Healthcare Technologies Inc

GE Healthcare Technologies Inc has a market price of $61.72, with a market capitalization of $28.08 billion. The company's price-to-earnings ratio is 65.6, and its price-to-book ratio is 3.6. The enterprise value to EBITDA is 58.09, and the enterprise value to revenue is 7.3. The company's return on equity is 5.49%, and its return on assets is 1.34%. The debt-to-equity ratio is 1.18, and the current ratio is 1.06. The company's profitability and returns are below the industry median for return on equity and return on assets. The gross profit margin is 41.3%, and the operating margin is 12.6%. The net profit margin is 8.8%. These metrics indicate that the company is less efficient in converting revenue into profit compared to its peers in the Advanced Medical Equipment & Technology industry. The company's revenue is primarily concentrated in the United States, with a significant portion of its revenue derived from North America. The company has a presence in other regions, but the majority of its operations and revenue are based in the United States. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is expected to be moderate, with a projected revenue increase of 4.5% in the current fiscal year and 3.2% in the next fiscal year. The company's capital expenditure is negative, indicating a reduction in investment in physical assets. The free cash flow is $506 million, which is a positive indicator of the company's ability to generate cash from operations. The company faces several risk factors, including liquidity risk due to negative net cash after subtracting total debt. The dilution potential is low, but the company's debt-to-equity ratio of 1.18 suggests a moderate level of financial leverage. The company's liquidity risk is medium, and its credit risk is moderate due to its debt levels and cash flow generation. Recent events include the company's focus on expanding its digital health offerings and investing in artificial intelligence for medical imaging. The company has also been involved in strategic partnerships to enhance its product portfolio and market reach. These developments indicate the company's efforts to innovate and maintain its competitive position in the healthcare technology sector.